We are pleased to announce that Clinical and Experimental Medicine will become a fully open access (OA) on 1 January 2024. As a result, all submissions received from 25thOctober 2023 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access.
This is a transformative journal, you may have access to funding.
We are excited to announce that Clinical and Experimental Medicine will become a fully open access (OA) journal in 2024. This means that as of January 2024, we will only be publishing open access articles, meaning content will be freely available to readers worldwide, enabling the widest possible dissemination and reuse.
Springer Nature is committed to ensuring our portfolios serve and meet the evolving needs of the research community and that quality research is read and disseminated as widely as possible. Transforming Clinical and Experimental Medicine to full OA reflects our ongoing commitment to driving the transition to open research, and providing researchers with OA publication venues that can amplify their research and enable compliance with funder and institutional OA requirements, while continuing to deliver a high level of author service. See our FAQs for further information.
Frequently asked questions regarding the transition to fully open access and what this means for the Clinical and Experimental Medicine.
Content will be freely available to readers worldwide!
The Clinical Practice topical collection aims to provide clinicians with the latest clinically relevant insights on a range of topics that would result in the enhancement of their knowledge and improvement of patient care. The topics may vary from clinical immunology and rheumatology to hematology, oncology and internal medicine in more general terms.
The collection is open to submissions from experienced authors.